Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-α2a: 1 year follow-up of the OSST study
| Image |  |
|---|---|
| Description | scientific article published on 06 January 2016 |
| Author/s | |
| Publication date | January 6, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |